Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Contineum Therapeutics (CTNM) Return on Capital Employed (2024 - 2025)

Contineum Therapeutics (CTNM) has 2 years of Return on Capital Employed data on record, last reported at 0.38% in Q3 2025.

  • For Q3 2025, Return on Capital Employed fell 17.0% year-over-year to 0.38%; the TTM value through Sep 2025 reached 0.38%, down 17.0%, while the annual FY2024 figure was 0.31%, N/A changed from the prior year.
  • Return on Capital Employed reached 0.38% in Q3 2025 per CTNM's latest filing, down from 0.36% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.09% in Q1 2024 and bottomed at 0.38% in Q3 2025.